7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... #DOAC #VTE #Malignancy ... Anticoagulation #Management
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... ” an infant with ... Procalcitonin <0.5 ng/mL ... #Diagnosis #Management ... #Pediatrics #Peds
The Febrile Infant Step-by-Step Algorithm
This is an algorithm developed by European emergency physicians to identify low-risk
to identify low-risk ... empiric antibiotic treatment ... Diagnosis #EBM #Management ... #Pediatrics #Peds ... #Antibiotics #Risk
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... e.g., <50%), ESC guidelines ... teratogenic GDMT meds ... Serial TTE and close ... #cardiology #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
PV, MDS, CML) Treatment ... • Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... #diagnosis #management